Matthew C. Kapusta - 19 Mar 2023 Form 3 Insider Report for Decibel Therapeutics, Inc.

Role
Director
Signature
Jeffrey Schulz, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Mar 2023
Net transactions value
$0
Form type
3
Filing time
21 Mar 2023, 16:10:29 UTC
Previous filing
09 Mar 2023
Next filing
25 Sep 2023

No securities are beneficially owned.

Remarks:

Exhibit Index: 24.1 Power of Attorney